After Amarin's tussle with investor group Sarissa Capital led to a restructuring and a board shuffle, the struggling drugmaker is undergoing its third CEO shake-up in just over a year.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Amarin Corp (AMRN) stock drops after CEO resignation and commercial update on Vascepa coverage by a major national pharmacy ...

Amarin (NASDAQ:AMRN) is trading over +15% premarket on Wednesday after it estimated $72M-$74M in preliminary Q4 revenues, significantly higher than the current consensus of $62.03M. Full year ...

Patrick Holt to Step Down as President & CEO to Pursue Other Opportunities -- DUBLIN and BRIDGEWATER, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that ...

By Chris Wack Amarin said in a filing with the U.S. Securities and Exchange Commission that it was informed by a large national pharmacy benefit ...

Ireland-headquartered fish oil-based heart drug specialist Amarin Corporation announced that it has appointed Aaron Berg, currently Amarin’s executive vice president and president of the US business, ...

Respawn Button by Barnaby Yu is a finalist in the 2024 First Page student writing challenge in the Grades 7 to 9 category for ...

The LA BOUTIQUE flagship store at Gaysorn Amarin is designed to offer an exclusive and luxurious shopping experience, ...

Good day, and welcome to Amarin Corporation's Conference Call to discuss its First Quarter 2024 Financial Results and Business Update. I would now like to turn the conference over to Mark Marmur ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...